• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Efficacy and Safety of Wuling Powder and Western Medicine in Treatment of Hyperuricemia: A Meta-analysis of Clinical Trials

    2021-10-21 08:53:04QiushuangLIZheLIQingyuXIEKunZHANGGuangRONGPingxinHAN
    Medicinal Plant 2021年4期
    關(guān)鍵詞:痹癥五苓散白虎

    Qiushuang LI, Zhe LI, Qingyu XIE, Kun ZHANG, Guang RONG*, Pingxin HAN

    1. Biomedicine Department of Beijing City University, Beijing 100094, China; 2.Dongzhimen Hospital, Beijing 100700, China; 3. Chengdu Yilian Technology Co., Ltd., Chengdu 610041, China

    Abstract [Objectives] To compare the clinical efficacy and safety of Wuling powder and conventional Western medicine for lowering uric acid in the treatment of hyperuricemia. [Methods] Databases such as CNKI, Wanfang Data, VIP Database, PubMed, Cochrane library and Embase, were retrieved, and comparative experiments of efficacy (serum uric acid level) and safety (incidence of adverse reactions) between Wuling powder (used singly or combined with other prescriptions) and conventional Western medicine in the treatment of hyperuricemia were included, and effect size was pooled with Revman 5.3. [Results] A total of 11 articles, involving 817 patients, were included, and their research quality was evaluated to be low. In terms of overall effect, Wuling powder (used singly or combined with other prescriptions) was better than the control drug in reducing serum uric acid level, but the difference was insignificant [SMD=-0.37, 95% CI (-0.90, 0.16)]. The heterogeneity between studies was high. The incidence of adverse reactions in the experimental group was significantly lower than that in the control group. Subgroup analysis shows that Wuling powder combined with other prescriptions was better than the control drug in reducing serum uric acid level [SMD=-0.37, 95% CI (-0.90, 0.16), P=0.17], and the heterogeneity was reduced. [Conclusions] Wuling powder combined with other prescriptions is better than conventional Western medicine in the treatment of hyperuricemia, and has better safety. Wuling powder alone is not as effective as conventional Western medicine. It is suggested that in clinical work, doctors may need to modify the prescription of Wuling powder. The low quality of the literature supporting this conclusion suggests that this evidence should be interpreted with caution.

    Key words Hyperuricemia, Wuling powder, Meta-analysis

    1 Introduction

    Hyperuricemia (HU) is a pathological state that occurs when the level of serum uric acid (SUA) increases due to abnormal production and/or excretion of SUA, and exceeds a critical value[1]. In recent years, the incidence rate of HU has been increasing in China year by year, 21.7% in men and 8.6% in women, equal to the levels of developed countries[2]. HU is an independent risk factor leading to labor loss. It is also related to the occurrence of atherosclerosis[3], myocardial infarction[4], diabetes[5]and hypertension[6]. HU is a sufficient and non-necessary condition for gout[7]. Among HU patients, 18.8% will progress to gout within five years[8]. The acute onset of gout has a clear causal relationship with SUA level fluctuations[9]. Therefore, controlling the level of SUA is a key for the treatment of gout, and may improve the above-mentioned related diseases or adverse events.

    Conventional urate lowering therapies (ULTs) include allopurinol, benzbromarone and febuxostat. Studies have shown that the SUA-lowering effect of the three is satisfactory. However, allopurinol may cause severe allergic reactions such as Steven-Johnson syndrome and toxic epidermal necrolysis[10].A study[11]has shown that such allergic reactions are closely related to the genotype of commonHLA-B*5801 in Asians. Benzbromarone may also be hepatotoxic[12].Febuxostat can be used in cases of allopurinol allergy and renal insufficiency, but the price is very expensive[13]. Generally, it is only used when the patient cannot tolerate allopurinol[14]. Therefore, research on new methods to reduce SUA has very important clinical and social significance.

    Wuling powder is first recorded inTreatiseonFebrileandMiscellaneousDiseases, and it is widely used in the clinical treatment of HU[15]. Clinical study[16]has found that Wuling powder and its modified prescriptions may have a certain effect in reducing SUA. However, the study has a small sample size and insufficient test power, and the result may be positive due to sampling error. In addition, some patients in the study have differences in baseline disease, and the combination medication situation and medication time of the experimental group are different, making it difficult for clinicians to obtain intuitive conclusions to guide clinical practice. To this end, this research intended to carry out a meta-analysis to explore whether Wuling powder and its modified prescriptions actually have the effect of reducing SUA.

    2 Materials and methods

    2.1 Retrieval strategyThe databases of CNKI, Wanfang Data, VIP Database, PubMed, Embase and Cochrane were retrieved, and the retrieval time was from the establishment of each database to December, 2019. Taking CNKI as an example, the retrieval strategy for Chinese databases was as follows: (AB=痛風(fēng) or AB=痹癥 or AB=痹證 or AB=白虎歷節(jié) or AB=歷節(jié) or AB=高尿酸血癥) and FT=五苓散 and (FT=臨床觀察 or FT=隊(duì)列研究 or FT=療效觀察 or FT=對(duì)照); and taking PubMed as an example, the retrieval strategy for English databases was as follows: 1. exp gout/; 2. hyperuricemia$.tw.; 3. 1 or 2; 4. wu ling san.tw.; 5. wu lingsan.tw.; 6. wulingsan.tw.; 7. wu-ling- san.tw.; 8. $wu-ling-san.tw.; 9. wu-ling-san$.tw.; 10. or/4-9; 11. 3 and 10; 12.randomized controlled trial.pt.; 13. controlled clinical trial.pt.; 14. randomized.ab.; 15. placebo.ab.; 16. drugtherapy.fs.; 17. randomly.ab.; 18. trial.ab.; 19. groups.ab.; 20. or/12-19; 21. (animals not (humans and animals)).sh.; 22. 20 not 21; 23.11 and 22. Other data retrieval was adjusted accordingly.

    2.2 Inclusion and exclusion criteria

    2.2.1Inclusion criteria. (i) Article in which the subject is clearly diagnosed as HU; (ii) Intervention measures: patients in the control group of the article need to use at least one of the urate lowering therapies (alopurinol, benzbromarone and febuxostat), and patients in the treatment group should use Wuling powder singly or in combination with other Chinese medicine prescriptions (Single use of Wuling powder refers to using Wuling powder original prescription or modifying the prescription simply based on TCM syndrome differentiation. Combined use of Wuling powder and other Chinese medicine prescriptions refers to using Wuling powder combined with other prescriptions or Wuling powder-like prescriptions[17], and none Western medicine that has a direct effect on lowering uric acid is taken. If the treatment group and the control group evenly take a certain non-uric acid-lowering drug on the basis of Wuling powder or its combination with other prescriptions as the basic treatment, and the change in the observed effect of the drug is offset between the two groups, the article can be included).(iii) Outcome indicators: the outcome indicators in the article should include at least one of the following indicators, SUA and overall effect. (iv) Control trials that meet the above intervention measures and outcome indicators.

    2.2.2Exclusion criteria. (i) Animal experiments, expert experience, case reports,invitroexperiments,etc.; (ii) Clinical study without a control group; (iii) Clinical research on combined use with other Western medicines except western medicine for lowering uric acid;(iv) Repeated publication; (v) Gout complicated by other diseases; (vi) The outcome indicator of overall effect is mixed with non-SUA evaluation factors, such as the patient’s pain level, and the overall effect cannot be extracted through data processing; (vii) The original research is not standardized and has obvious errors; (viii) Research for which data cannot be extracted; (ix) Non-Chinese and non-English literature.

    2.3 Data extractionTwo reviewers cross-screened the literature, read the titles and abstracts, and excluded articles that did not meet the inclusion criteria. Then, they read through the full text of the articles that might meet the inclusion criteria. The results obtained by the two were checked, and if there was a dispute, a third party was invited to make a ruling.

    2.4 Outcome indicators(i) Main outcome indicator: SUA. (ii) Secondary outcome indicator: overall effect. Article including at least one of the above indicators was included.

    2.5 Quality evaluationAccording to the bias risk evaluation tool of Cochrane Reviewer’s Manual 5.1.0[18], the bias risk of the included studies was evaluated, including (i) whether the method is randomized; (ii) whether the allocation is hidden; (iii) whether there is a reasonable blinding method for participants and implementers; (iv) whether there is a reasonable blinding method for the outcome assessor; (v) whether the result data is incomplete, and whether to conduct loss to follow-up/withdrawal and intention analysis; (vi) whether there is selective reporting bias, and whether to report adverse reactions, uric acid value and other results; (vii) other sources of bias, such as the source of funds. The above items were evaluated by two persons synchronously, and if there was dispute, a third party was invited to make a ruling.

    2.6 Statistics and analysisMeta-analysis of outcome indicators was performed using Revman 5.3. Count data are expressed using relative risk (RR, risk ratio) and 95% confidence interval (95%CI), and measurement data are expressed using standard mean difference (SMD) and 95%CI. A heterogeneity test was performed on the included data. WhenI2≤50%, the heterogeneity is considered acceptable, and the fixed effects model is used; and whenI2>50%, the heterogeneity is considered large, and the random effects model is used[19]. When the random effects model was still highly heterogeneous, subgroup analysis was tried (if the number of articles actually included in a certain index was less than 2, the index would not be subjected to subgroup analysis) to explain the source of heterogeneity. The analysis result is shown in a forest plot. If the number of articles ≥ 10[20], Stata 12.0 was used to draw a funnel chart and perform Egger[21]and Begg[22]tests to quantitatively evaluate publication bias. WhenP≥0.1 in the test result, it is not enough to prove that the research has publication bias[23].

    3 Results and analysis

    3.1 Search resultsAccording to the retrieval strategy, a total of 409 articles were obtained, including 352 articles in CNKI, 49 articles in Wanfang Data, and 8 articles in VIP Database. None related article was retrieved in PubMed, Embase and Cochrane Library. After eliminating 21 duplicate articles and 377 articles based on the reasons in Fig.1, 11 articles were finally included[24-34]. The literature retrieval and screening process is shown in Fig.1.

    Fig.1 Flow chart of literature retrieval

    3.2 Features of included literatureThe basic characteristics of the included literature are shown in Table 1. The included subjects were all clearly diagnosed as HU, and all the literature clearly reported the diagnosis basis. In all the articles, Wuling powder (used singly or in combination with other prescriptions) was used in the experimental group, and conventional Western medicine was used in the control group.

    Table 1 Features of included literature

    3.3 Quality evaluationThe results of the Cochrane systematic review show that the 11 articles[24-34]were all grouped by random methods, random number table method in 2 articles[33-34], numbering-based random grouping in one article[27], admission order-based grouping in one article[25], and simple random methods in the rest articles. None of the articles mentions allocation concealment, one article[29]uses the single-blind method, and one article[32]mentions withdrawal and dropout cases. The methodological characteristics are detailed in Table 2. The evaluation results of the bias risk are shown in Fig.2.

    Fig.2 Analysis results of bias risk of included literature

    Table 2 Methodological quality evaluation of included literature

    3.4 Meta-analysisIn the literature included in this study, the outcome indicators include the SUA level. The evaluation of the overall effect in most of the included literature is based on the evaluation method for the overall effect on gout (GuidingPrinciplesforClinicalResearchofNewDrugs[35-37], which does not list the evaluation method for the overall effect on serum uric acid level), and the indicators also cover non-SUA indicators such as patient’s pain level. We believe that improving the actual symptoms of patients is the focus of clinical research evaluation and should be paid attention to. However, the main purpose of this study is to explore the influence of the experimental drug on the level of SUA, and in the clinic, HU patients are not necessarily accompanied by gout, and patients with gout may also not be accompanied by HU due to good medication control. Therefore, the overall effect reported in these articles was not included in the study.

    ResearcherCochrane systematic reviewRandomizationmethodBlinding methodAllocationconcealmentWithdrawal andloss to follow-upSelectivereportOther biasHao Manxia[28]Only mentioning randomizationNot mentionedNot mentionedUnclearUnclearUnclearWang Fang[29]Random single blind methodSingle blind methodNot mentionedUnclearUnclearUnclearMiao Jun[30]Only mentioning randomizationNot mentionedNot mentionedUnclearUnclearUnclearGuo Guoxing[31]Only mentioning randomizationNot mentionedNot mentionedUnclearUnclearUnclearChen Zhiyan[32]Randomized, controlledNot mentionedNot mentioned2 cases excluded inthe control group;2 cases dropped outin the treatment group UnclearUnclearJin Lanhua[33]Random number tableNot mentionedNot mentionedUnclearUnclearUnclearLi Zhongwan[34]Random number tableNot mentionedNot mentionedUnclearUnclearUnclear

    Taking SUA as the observation index, a heterogeneity test (I2=92%) was performed on the 11 articles, and it is indicated that there is a certain degree of heterogeneity between the studies, so the random effects model is adopted for meta-analysis. The results show thatSMD=-0.37, 95%CI(-0.90, -0.16), andP=0.17, without statistical difference between the two groups, indicating that the treatment group was not evidently better than the control group in reducing SUA level in HU patients, so further subgroup analysis was required (Fig.3).

    Fig.3 SUA forest plot

    3.5 Subgroup analysisThe results of meta-analysis show that the heterogeneity of the research is great, so subgroup analysis was conducted based on the use of Wuling powder alone and in combination with other prescriptions to try to explain the source of heterogeneity.

    3.5.1Subgroup analysis of original prescription and modified prescription of Wuling powder. The treatment groups of total 6 articles[24-25, 28, 32-34]used Wuling powder alone, and the rest 5 articles[26-27, 29-31]used Wuling powder in combination with other Chinese medicines. The results of the SUA subgroup analysis are shown in Fig.4.

    Fig.4 SUA forest plot of subgroups of original and modified prescriptions of Wuling powder

    3.6 Safety analysisA total of 4 articles[26-27, 30, 32]reported adverse reactions, and none of the others reported. The results showed that 1 case of diarrhea occurred in the treatment group, and 16 cases of gastrointestinal reactions, 5 cases of drug intolerance, 3 cases of dizziness, 2 cases of leukopenia, and 1 case of allergic rash appeared in the control group. The incidence of adverse reactions in the treatment group was 0.48% (1/208), and that in the control group was 16.36% (27/165). The difference is statistically significant [RR=0.07, 95%CI(0.02, 0.24),P<0.000 1], indicating the use of Wuling powder combined with other prescriptions to treat HU has a lower incidence of adverse reactions than conventional Western medicines for lowering uric acid (Fig.5).

    Fig.5 Forest plot of adverse reaction incidence

    3.7 Analysis of publication biasThe publication bias of SUA is elucidated using a funnel chart. The results of Egger’s test (t=-0.13,P>0.901) show that there was no significant publication bias (Fig.6), but those of Begg’s test (Z=0.180,P=0.200) show that there was significant publication bias in the SUA level (Fig.7).

    Fig.6 Funnel plot of SUA publication bias

    Note: 1. Wuling powder alone; 2. Original and modified prescriptions of Wuling powder.

    4 Discussion

    A total of 11 articles were included in this study, involving 817 patients. The analysis results show that although the overall effect of Wuling powder (used singly or in combination with other prescriptions) is more effective in reducing patients’ SUA level than conventional uric acid-lowering drugs, but the difference is not statistically significant. What is more, there is great heterogeneity among the studies. Subgroup analysis found that compared with conventional SUA-lowering western medicine, Wuling powder has a better effect in reducing patients’ SUA level when combined with other prescriptions (except for single use), with statistical difference, and the heterogeneity between groups also decreased.

    Existing experimental research shows that Wuling powder should indeed have a certain effect in the treatment of HU, and the main mechanism is to increase the excretion of urine, sodium, urea,etc., similar to that of benzbromarone[38-43]. This study found that the effect of Wuling powder single use subgroup was not better than that of the control drug (the difference from the control drug was not statistically significant,P=0.20), indicating that although Wuling powder alone has no advantage over the control drug, it is at least equivalent in effect, consistent with the finding of the above study that its onset mechanism is similar to western medicine.

    In addition, it was observed that in the subgroup of Wuling powder modified prescriptions, the compatible prescriptions used commonly include Yinchen Wuling powder, Pingwei powder, Simiao powder and Simiao Yongan decoction, and the single herbs used commonly included Herba Artemisiae Capillariae, Rhizoma Atractylodis and Cortex Magnoliae Officinalis. The above-mentioned prescriptions and herbs have all been reported clinically and experimentally, providing evidence for their effectiveness and mechanisms[44-46], and corroborating the results of this study.

    Traditional Western medicines such as allopurinol, febuxostat and benzbromarone have been the basic drugs for the treatment of HU for decades, but a certain amount of adverse events have been reported[47-50]. Traditional Chinese medicine believes that gout-related diseases belong to the categories of "pyretic arthralgia" and "pain arthralgia", and their treatment is based on the principle of "activating blood circulation, relieving pain, promoting urination and excreting dampness"[51]. According toTreatiseonFebrileDiseases, the pathogenesis of the diseases treated with Wuling powder prescription is the abnormal metabolism of fluid in the body, and Wuling powder is a representative prescription for strengthening the spleen, exuding dampness and promoting urination[52]. Pharmacological studies have shown that Wuling powder can increase urine output and increase the excretion of Na+, K+and Cl-in urine, and its diuretic and sodium excretion effect approaches or exceeds that of western diuretics[53]. This is in line with the understanding of Chinese medicine, and is the same as the treatment principle of promoting uric acid excretion in Western medicine. The results of this study show that the incidence of adverse reactions in the Western medicine group was 12.16%, while that in the Wuling powder group was only 1.34%, indicating that Wuling powder has a low incidence of adverse reactions. When Wuling powder is used with allopurinol, in addition to promoting uric acid excretion and inhibiting uric acid production, it is possible to avoid the disadvantages of increased risk of adverse events when two types of Western medicine are used in combination.

    The main advantage of this study is that the experimental groups of all the included articles used Wuling powder alone or in combination with other prescriptions (except conventional Western medicines for lowering uric acid), and the final overall effect is entirely from traditional Chinese medicine. Subgroup analysis was used to compare the effect of Wuling powder used singly or in combination with other traditional Chinese medicines and conventional therapies, and it was found that Wuling powder combined with other traditional Chinese medicines has a significantly better uric acid lowering effect than the control drugs. This provides evidence for how to choose prescriptions and medications for hyperuricemia.

    The meta-analysis in this study has certain limitations, dominated by low methodological quality of the included studies and the small number of included trials. Among the 11 articles, only 4 articles[26-27, 29, 32]describe randomization methods. None of the articles mentioned allocation concealment or blinding. The quality of the research involved in this study is low, so the results may be biased. The included studies have a small sample size, and the systematic error caused by the "small sample research effect" cannot be ruled out[54]. In addition, only 4 of the 11 articles[26-27, 30, 32]described adverse reactions. Due to insufficient description, the count data of adverse reactions is not comprehensive. Therefore, with the development of large-scale, well-designed randomized controlled trials, a more reasonable method is needed to evaluate the adverse reactions and clinical efficacy of Wuling powder. Limited by the number of documents that meet the criteria for inclusion, this study was unable to pass subgroup analysis. Which prescription used in combination with Wuling powder has the best effect needs further study.

    The above results indicate that traditional classic prescriptions can achieve satisfactory results in the treatment of HU when used under the guidance of the theory of syndrome differentiation. Clinically, based on syndrome differentiation, modifying the prescription appropriately may achieve better results. But limited by the number of existing studies, it is yet unable to conduct a sufficient subgroup analysis to distinguish whether this therapeutic advantage comes from other prescriptions used in combination or the interaction between these prescriptions and Wuling powder. Therefore, by combining previous reports and the results of this research, based on the above discussion and analysis, we infer that the effect and mechanism of Wuling powder to reduce SUA should be similar to those of benzbromarone. When combined with other prescriptions with non-diuretic mechanism, a better result will be achieved than Wuling powder alone. In addition, the disadvantage of increased risk of adverse events when two types of Western medicine are used in combination may be avoided.

    5 Conclusions

    Wuling powder combined with other prescriptions is better than conventional Western medicine in treating HU, with good safety. Wuling powder alone is not as effective as conventional Western medicine. In clinical work, doctors may need to modify the prescription of Wuling powder. The low quality of the literature supporting this conclusion suggests that this evidence should be interpreted with caution.

    猜你喜歡
    痹癥五苓散白虎
    從“痹癥有瘀血說(shuō)”論治膝關(guān)節(jié)骨性關(guān)節(jié)炎
    基于數(shù)據(jù)挖掘丹葛五苓散治療CHF作用機(jī)制及實(shí)驗(yàn)驗(yàn)證
    國(guó)醫(yī)大師唐祖宣應(yīng)用五苓散經(jīng)驗(yàn)
    為何說(shuō)西瓜是『天然白虎湯』
    針灸聯(lián)合茵陳五苓散加減治療男性濕熱上蒸型脂溢性脫發(fā)的效果分析
    五苓散治盜汗
    特別健康(2018年4期)2018-07-03 00:38:16
    中藥熏洗治療膝骨性關(guān)節(jié)炎35例臨床觀察
    體、火針結(jié)合治療類風(fēng)濕性關(guān)節(jié)炎42例療效觀察
    白虎
    火花(2015年6期)2015-02-27 07:42:54
    白虎消痤湯加減治療濕熱蘊(yùn)結(jié)型痤瘡47例
    一进一出抽搐gif免费好疼| 久久久午夜欧美精品| av天堂在线播放| 午夜福利18| 亚洲美女视频黄频| 亚洲av免费在线观看| 狂野欧美激情性xxxx在线观看| 亚洲国产欧洲综合997久久,| 黄色视频,在线免费观看| 卡戴珊不雅视频在线播放| 给我免费播放毛片高清在线观看| 午夜激情福利司机影院| 亚洲av电影不卡..在线观看| 观看免费一级毛片| 欧美高清成人免费视频www| 亚洲欧美日韩东京热| 国产毛片a区久久久久| 身体一侧抽搐| 国产精品国产高清国产av| 青春草视频在线免费观看| 欧美+日韩+精品| 日本成人三级电影网站| 又粗又爽又猛毛片免费看| 久久精品久久久久久噜噜老黄 | 成人亚洲精品av一区二区| 男女那种视频在线观看| 欧美高清成人免费视频www| 网址你懂的国产日韩在线| 免费在线观看影片大全网站| 深夜a级毛片| 国产成年人精品一区二区| 俄罗斯特黄特色一大片| 欧美xxxx黑人xx丫x性爽| 男人和女人高潮做爰伦理| 国产69精品久久久久777片| 乱码一卡2卡4卡精品| 97超碰精品成人国产| 小说图片视频综合网站| 蜜臀久久99精品久久宅男| 国产精品久久久久久精品电影| 男女边吃奶边做爰视频| 久久韩国三级中文字幕| 能在线免费观看的黄片| 亚洲久久久久久中文字幕| 大又大粗又爽又黄少妇毛片口| 亚洲最大成人中文| 国产高潮美女av| eeuss影院久久| 久久中文看片网| 深爱激情五月婷婷| 亚洲四区av| 免费看日本二区| 国内精品久久久久精免费| 熟妇人妻久久中文字幕3abv| 日本-黄色视频高清免费观看| 午夜福利18| 免费高清视频大片| 岛国在线免费视频观看| 午夜爱爱视频在线播放| 一级av片app| 国产在线精品亚洲第一网站| 国产精品99久久久久久久久| 亚洲第一区二区三区不卡| 婷婷色综合大香蕉| 女生性感内裤真人,穿戴方法视频| 免费搜索国产男女视频| 国产精品美女特级片免费视频播放器| 亚洲不卡免费看| 亚洲精华国产精华液的使用体验 | 欧美+亚洲+日韩+国产| 菩萨蛮人人尽说江南好唐韦庄 | 搡老熟女国产l中国老女人| 欧美日韩一区二区视频在线观看视频在线 | 国产高清有码在线观看视频| 能在线免费观看的黄片| av黄色大香蕉| 国产伦一二天堂av在线观看| 人妻夜夜爽99麻豆av| 在线观看一区二区三区| 狂野欧美激情性xxxx在线观看| 日本一二三区视频观看| 免费看日本二区| 亚洲av中文字字幕乱码综合| av天堂中文字幕网| 亚洲真实伦在线观看| 高清日韩中文字幕在线| 嫩草影院新地址| 久99久视频精品免费| 尤物成人国产欧美一区二区三区| 国产伦在线观看视频一区| 1000部很黄的大片| 97人妻精品一区二区三区麻豆| 哪里可以看免费的av片| 亚洲五月天丁香| 一级黄片播放器| 又黄又爽又刺激的免费视频.| 亚洲最大成人中文| 午夜福利在线在线| 十八禁网站免费在线| 久久韩国三级中文字幕| 亚洲一区高清亚洲精品| 麻豆一二三区av精品| 女同久久另类99精品国产91| 国产精品福利在线免费观看| 长腿黑丝高跟| 高清毛片免费观看视频网站| 老司机午夜福利在线观看视频| 国产av麻豆久久久久久久| 日本成人三级电影网站| www日本黄色视频网| 狂野欧美激情性xxxx在线观看| 99久国产av精品国产电影| 中文字幕免费在线视频6| 午夜免费男女啪啪视频观看 | 国产亚洲精品久久久com| 精品日产1卡2卡| 日韩欧美在线乱码| 国内精品美女久久久久久| 久久久成人免费电影| 搡老妇女老女人老熟妇| 51国产日韩欧美| 成人美女网站在线观看视频| 女同久久另类99精品国产91| 久久精品国产自在天天线| 日韩欧美免费精品| 一进一出抽搐动态| 免费观看精品视频网站| 中文字幕久久专区| 亚洲精品一卡2卡三卡4卡5卡| 色在线成人网| 噜噜噜噜噜久久久久久91| 老司机影院成人| 级片在线观看| 欧美不卡视频在线免费观看| 少妇人妻一区二区三区视频| 国产精品日韩av在线免费观看| 日本一二三区视频观看| 久久精品国产鲁丝片午夜精品| 国内精品一区二区在线观看| 亚洲欧美日韩无卡精品| 国产欧美日韩精品亚洲av| 日本一二三区视频观看| 天堂影院成人在线观看| 亚洲av五月六月丁香网| 国产一区二区三区av在线 | 亚洲高清免费不卡视频| 国产v大片淫在线免费观看| 在线播放无遮挡| 欧美人与善性xxx| 亚洲精品亚洲一区二区| 九色成人免费人妻av| 亚洲av免费高清在线观看| 国产av一区在线观看免费| 看十八女毛片水多多多| 日产精品乱码卡一卡2卡三| 国产精品日韩av在线免费观看| 日韩亚洲欧美综合| 丝袜喷水一区| 欧美最新免费一区二区三区| 男人舔女人下体高潮全视频| 精品免费久久久久久久清纯| 日本黄色片子视频| 日韩在线高清观看一区二区三区| 22中文网久久字幕| 国产国拍精品亚洲av在线观看| 国产精华一区二区三区| 亚洲国产精品国产精品| 国语自产精品视频在线第100页| 精品久久久久久久久亚洲| 午夜亚洲福利在线播放| 麻豆av噜噜一区二区三区| 亚洲av五月六月丁香网| 亚洲色图av天堂| eeuss影院久久| 欧美激情在线99| 成人亚洲精品av一区二区| 国内精品一区二区在线观看| 亚洲精品成人久久久久久| а√天堂www在线а√下载| 亚洲成a人片在线一区二区| 日韩在线高清观看一区二区三区| 人人妻,人人澡人人爽秒播| 成人特级av手机在线观看| 亚洲人与动物交配视频| 亚洲丝袜综合中文字幕| 1000部很黄的大片| 亚洲内射少妇av| 亚洲国产色片| 看片在线看免费视频| 22中文网久久字幕| 色综合站精品国产| 成人av在线播放网站| 大又大粗又爽又黄少妇毛片口| 悠悠久久av| 国产 一区 欧美 日韩| 日本黄色视频三级网站网址| 在线免费观看的www视频| 免费观看的影片在线观看| 国产又黄又爽又无遮挡在线| 欧美区成人在线视频| 久久久久久伊人网av| 春色校园在线视频观看| 久久久精品大字幕| 成人av一区二区三区在线看| 长腿黑丝高跟| 最近2019中文字幕mv第一页| 真人做人爱边吃奶动态| 男女啪啪激烈高潮av片| 久久久精品欧美日韩精品| 在线看三级毛片| 中国美白少妇内射xxxbb| 日韩欧美精品v在线| 精品免费久久久久久久清纯| 午夜福利成人在线免费观看| 欧美激情久久久久久爽电影| 日本 av在线| 性色avwww在线观看| 男女那种视频在线观看| 两个人的视频大全免费| 有码 亚洲区| 中文字幕精品亚洲无线码一区| 久久久久久久久中文| 日本与韩国留学比较| 日韩成人av中文字幕在线观看 | 看非洲黑人一级黄片| 六月丁香七月| 老女人水多毛片| 日韩欧美 国产精品| 国国产精品蜜臀av免费| 久久久久性生活片| 成人永久免费在线观看视频| 搡老岳熟女国产| 亚洲婷婷狠狠爱综合网| 国产 一区 欧美 日韩| 两个人的视频大全免费| 日韩强制内射视频| 女人被狂操c到高潮| 国产毛片a区久久久久| 亚洲综合色惰| 久久九九热精品免费| 亚洲av中文字字幕乱码综合| 亚洲乱码一区二区免费版| 日本爱情动作片www.在线观看 | 我的女老师完整版在线观看| 欧美色视频一区免费| 亚洲美女黄片视频| 在线观看美女被高潮喷水网站| 中文字幕免费在线视频6| 国产精品亚洲一级av第二区| 国产精品一区二区三区四区久久| 久99久视频精品免费| 亚洲无线观看免费| 一a级毛片在线观看| 最后的刺客免费高清国语| 免费观看精品视频网站| 亚洲精品在线观看二区| av在线播放精品| 欧洲精品卡2卡3卡4卡5卡区| 亚洲电影在线观看av| 女生性感内裤真人,穿戴方法视频| 桃色一区二区三区在线观看| 国内精品一区二区在线观看| 国产私拍福利视频在线观看| 午夜爱爱视频在线播放| 欧美+日韩+精品| 在线观看一区二区三区| 毛片女人毛片| 小蜜桃在线观看免费完整版高清| 亚洲精品一区av在线观看| 亚洲国产欧美人成| 亚洲av熟女| 麻豆精品久久久久久蜜桃| 亚洲无线观看免费| av在线观看视频网站免费| 国产一区二区亚洲精品在线观看| 麻豆av噜噜一区二区三区| 亚洲av二区三区四区| 精品午夜福利在线看| 美女 人体艺术 gogo| 日本熟妇午夜| 久久精品国产清高在天天线| 精品人妻熟女av久视频| 日韩国内少妇激情av| 我的女老师完整版在线观看| 欧美xxxx性猛交bbbb| 国产毛片a区久久久久| 亚州av有码| 秋霞在线观看毛片| 精品福利观看| АⅤ资源中文在线天堂| 国产亚洲欧美98| 大香蕉久久网| 99国产极品粉嫩在线观看| 午夜老司机福利剧场| 国产伦一二天堂av在线观看| 久久99热这里只有精品18| 天天躁日日操中文字幕| av在线老鸭窝| av天堂在线播放| 久久久久国内视频| 精品一区二区三区av网在线观看| 黄色配什么色好看| 久久久精品94久久精品| 美女高潮的动态| 小说图片视频综合网站| 十八禁网站免费在线| 99热这里只有是精品在线观看| 小说图片视频综合网站| 久久综合国产亚洲精品| 日韩欧美国产在线观看| 三级国产精品欧美在线观看| 国国产精品蜜臀av免费| 99热这里只有精品一区| 日本-黄色视频高清免费观看| 国产一区二区三区在线臀色熟女| 久久精品国产鲁丝片午夜精品| 久久欧美精品欧美久久欧美| 俄罗斯特黄特色一大片| 国内久久婷婷六月综合欲色啪| 日本黄大片高清| 99九九线精品视频在线观看视频| 最近最新中文字幕大全电影3| 亚洲成人精品中文字幕电影| 一本久久中文字幕| 成人精品一区二区免费| 国产不卡一卡二| 人妻少妇偷人精品九色| 免费无遮挡裸体视频| 少妇的逼好多水| 晚上一个人看的免费电影| 免费在线观看影片大全网站| av在线播放精品| 一级毛片aaaaaa免费看小| 亚洲av中文av极速乱| 美女内射精品一级片tv| 国产激情偷乱视频一区二区| 一a级毛片在线观看| 精品人妻熟女av久视频| 国语自产精品视频在线第100页| 成年女人永久免费观看视频| 中文字幕免费在线视频6| 男女啪啪激烈高潮av片| 精品久久久久久久末码| 日韩欧美在线乱码| av免费在线看不卡| 免费看av在线观看网站| 身体一侧抽搐| 日韩av在线大香蕉| 中文字幕av在线有码专区| 久久精品国产亚洲av香蕉五月| 久久人人爽人人片av| 精品不卡国产一区二区三区| 舔av片在线| 日本在线视频免费播放| 亚洲真实伦在线观看| 国产亚洲av嫩草精品影院| 亚洲欧美日韩东京热| 女生性感内裤真人,穿戴方法视频| 别揉我奶头 嗯啊视频| av中文乱码字幕在线| 男插女下体视频免费在线播放| 欧美人与善性xxx| 少妇的逼好多水| 日本三级黄在线观看| 国产三级中文精品| 亚洲va在线va天堂va国产| 一个人看视频在线观看www免费| 亚洲内射少妇av| 亚洲国产精品国产精品| 国产精品无大码| 久99久视频精品免费| 成人亚洲欧美一区二区av| 黄色视频,在线免费观看| 亚洲av成人精品一区久久| 亚洲激情五月婷婷啪啪| 在线观看午夜福利视频| 免费av观看视频| 丰满人妻一区二区三区视频av| 免费看av在线观看网站| 精品熟女少妇av免费看| 欧美性猛交╳xxx乱大交人| 黄色欧美视频在线观看| 国产伦精品一区二区三区视频9| a级毛色黄片| 在线观看免费视频日本深夜| 99九九线精品视频在线观看视频| 又爽又黄a免费视频| 18禁黄网站禁片免费观看直播| 国产淫片久久久久久久久| 亚洲成人av在线免费| 日本a在线网址| 少妇的逼水好多| 亚洲一级一片aⅴ在线观看| 国产单亲对白刺激| 日韩人妻高清精品专区| 禁无遮挡网站| 日韩欧美在线乱码| 色吧在线观看| 女的被弄到高潮叫床怎么办| 又粗又爽又猛毛片免费看| 婷婷六月久久综合丁香| 麻豆成人午夜福利视频| 精品不卡国产一区二区三区| 观看美女的网站| 久久久久久久久中文| 波多野结衣高清作品| 校园春色视频在线观看| 日本五十路高清| 久久午夜亚洲精品久久| 网址你懂的国产日韩在线| 变态另类丝袜制服| 欧美国产日韩亚洲一区| 国产精品无大码| 精品人妻熟女av久视频| 精品一区二区三区视频在线观看免费| 91久久精品国产一区二区成人| 97超碰精品成人国产| 欧美精品国产亚洲| 国产大屁股一区二区在线视频| 成人三级黄色视频| 亚洲成人久久爱视频| 午夜福利在线观看免费完整高清在 | 人人妻,人人澡人人爽秒播| 在现免费观看毛片| 国产高清不卡午夜福利| а√天堂www在线а√下载| 久久亚洲国产成人精品v| 99在线人妻在线中文字幕| 老女人水多毛片| 精品国产三级普通话版| 女人被狂操c到高潮| 男女啪啪激烈高潮av片| 老司机影院成人| 黄色日韩在线| 少妇裸体淫交视频免费看高清| 18+在线观看网站| 亚洲18禁久久av| 国产综合懂色| avwww免费| 一级av片app| 又粗又爽又猛毛片免费看| 精品欧美国产一区二区三| 欧美最新免费一区二区三区| 91久久精品国产一区二区成人| 伦精品一区二区三区| 免费观看在线日韩| 日本a在线网址| 看片在线看免费视频| АⅤ资源中文在线天堂| 真实男女啪啪啪动态图| 高清日韩中文字幕在线| 亚洲美女搞黄在线观看 | 国产久久久一区二区三区| 一级a爱片免费观看的视频| 日本黄色片子视频| 久久欧美精品欧美久久欧美| 国产黄色视频一区二区在线观看 | 亚洲第一电影网av| 婷婷色综合大香蕉| 国产v大片淫在线免费观看| 人人妻人人澡欧美一区二区| aaaaa片日本免费| 国内少妇人妻偷人精品xxx网站| 久久九九热精品免费| 国产精品亚洲一级av第二区| 97热精品久久久久久| h日本视频在线播放| 色播亚洲综合网| 午夜免费男女啪啪视频观看 | 97超碰精品成人国产| 国国产精品蜜臀av免费| 麻豆一二三区av精品| 国产成人福利小说| 免费观看精品视频网站| 亚洲国产欧洲综合997久久,| 国产色爽女视频免费观看| 日日撸夜夜添| 老师上课跳d突然被开到最大视频| 久久精品夜夜夜夜夜久久蜜豆| 极品教师在线视频| 亚洲乱码一区二区免费版| 亚洲一区高清亚洲精品| 亚洲精品在线观看二区| 99热6这里只有精品| 12—13女人毛片做爰片一| 亚洲国产精品成人久久小说 | 天天躁夜夜躁狠狠久久av| 乱系列少妇在线播放| 日韩欧美 国产精品| 熟女人妻精品中文字幕| 99久久久亚洲精品蜜臀av| 欧美色视频一区免费| 精品一区二区三区人妻视频| 老司机影院成人| 麻豆久久精品国产亚洲av| 老司机影院成人| 悠悠久久av| 国产精品一区www在线观看| 两个人的视频大全免费| 久久久国产成人免费| 在线a可以看的网站| 欧美成人a在线观看| 国产精品1区2区在线观看.| 亚洲五月天丁香| 又黄又爽又免费观看的视频| 亚洲欧美日韩卡通动漫| 少妇高潮的动态图| 一个人观看的视频www高清免费观看| 亚洲av二区三区四区| 精品久久久久久久末码| 在线天堂最新版资源| 99久久精品国产国产毛片| 1000部很黄的大片| 狂野欧美白嫩少妇大欣赏| 波多野结衣高清无吗| 欧美3d第一页| 日韩欧美精品v在线| 欧美极品一区二区三区四区| 日韩中字成人| 久久久久久久久久久丰满| 色综合亚洲欧美另类图片| 国产单亲对白刺激| 欧美日韩精品成人综合77777| 99热6这里只有精品| 最好的美女福利视频网| 欧美成人精品欧美一级黄| 久久这里只有精品中国| 日韩欧美国产在线观看| 亚洲熟妇中文字幕五十中出| 人妻丰满熟妇av一区二区三区| 久久精品综合一区二区三区| 18+在线观看网站| 一个人免费在线观看电影| 亚洲国产精品合色在线| 毛片一级片免费看久久久久| 99视频精品全部免费 在线| 夜夜爽天天搞| 亚洲电影在线观看av| 最近在线观看免费完整版| 嫩草影视91久久| 久久人人爽人人片av| 97碰自拍视频| 午夜爱爱视频在线播放| 国产免费一级a男人的天堂| 午夜激情福利司机影院| 亚洲国产精品sss在线观看| 一卡2卡三卡四卡精品乱码亚洲| 久久久久久久久大av| 天堂网av新在线| 淫秽高清视频在线观看| 搡老熟女国产l中国老女人| 亚洲av熟女| 成人特级黄色片久久久久久久| 亚洲最大成人手机在线| 亚洲激情五月婷婷啪啪| 国产69精品久久久久777片| 日本 av在线| 欧美一级a爱片免费观看看| 国产男人的电影天堂91| 亚洲成av人片在线播放无| 99在线人妻在线中文字幕| 国产色爽女视频免费观看| 久久久久久久午夜电影| 国产成人一区二区在线| 六月丁香七月| 国产午夜福利久久久久久| 国产中年淑女户外野战色| 成人三级黄色视频| 99久久精品热视频| 国产又黄又爽又无遮挡在线| 哪里可以看免费的av片| 国产午夜精品论理片| 日日摸夜夜添夜夜爱| 全区人妻精品视频| 熟女人妻精品中文字幕| 亚洲精品日韩av片在线观看| 99热这里只有精品一区| 97超视频在线观看视频| 青春草视频在线免费观看| 成人漫画全彩无遮挡| 国产精品国产高清国产av| 春色校园在线视频观看| 精品人妻偷拍中文字幕| 中出人妻视频一区二区| 搡女人真爽免费视频火全软件 | 国产高清视频在线播放一区| 干丝袜人妻中文字幕| 久久这里只有精品中国| 99热精品在线国产| 听说在线观看完整版免费高清| 亚洲成av人片在线播放无| 欧美zozozo另类| 亚洲第一区二区三区不卡| 非洲黑人性xxxx精品又粗又长| 色噜噜av男人的天堂激情| 国产色爽女视频免费观看| or卡值多少钱| 成年版毛片免费区| 在线免费十八禁| 日韩欧美精品v在线| 国产 一区 欧美 日韩| 男女边吃奶边做爰视频| 人妻制服诱惑在线中文字幕| 亚洲四区av| 波多野结衣高清无吗| 亚洲美女搞黄在线观看 | 午夜免费男女啪啪视频观看| av国产精品久久久久影院| 久久人妻熟女aⅴ| 久久精品国产亚洲网站| 国产精品秋霞免费鲁丝片| 日韩欧美一区视频在线观看 | 五月开心婷婷网| 国产精品熟女久久久久浪| 少妇人妻一区二区三区视频|